Conference abstract · 2016
Conference abstractPublished 19 Nov 2012
Rod-derived cone viability factor for treating blindness
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In patients suffering from retinitis pigmentosa (RP), the most common form of inherited retinal degeneration, the vision loss develops in two successive steps: rod photo receptors loss precedes that of cones. This secondary event leads to central vision loss and potentially complete blindness. Because the cones underlie all visual functions in lighted environment, cone rescue was deemed to be a clinically relevant target. We have identified by high content screening a cDNA encoding the first 109 residues protein that was referred as Rod-derived Cone Viability Factor (RdCVF). The bifunctional Nucleoredoxin-like gene Nxnl1 encodes through alternative splicing for RdCVF, a truncated thioredoxin-like protein that is secreted from rods, and RdCVFL, a thioredoxin protein involved in redox signaling and protection against hyperoxia through its interaction with the microtubule-associated protein TAU. We evaluated the protective effects of AAV-mediated expression of these two isoforms in a recessive model of rod-cone dystrophy, the rd10 mouse. Intravenous injections of AAV-RdCVF engineered vectors slowed the rate of cone loss and increased the amplitude of the photopic electroretinogram. Expression of RdCVFL but not RdCVF reduced biproducts of oxidative stress. We also show that subretinal injection of AAV-RdCVF prevents the secondary loss of function of the cones in a dominant model of RP, the transgenic P23H rat. These results indicate distinct functions in the retina for these two Nxnl1 gene products, and suggest that RdCVF holds promise for treating retinal degenerative disease almost independently of the causative mutation.
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 19 Dec 2014
Porous tantalum rods for treating osteonecrosis of the femoral head
Article · 2012
Evaluation of procedures for quantification of CD34+haematopoietic stem cells and viability studies in umbilical cord blood derived mononuclear cells
Conference abstract · 8 Aug 2018
Efficacy and safety of transcutaneous electrical acupoint stimulation to treat muscle spasticity following brain injury: A double-blinded, multicenter, randomized controlled trial
Research article · 13 Apr 2015
Hypoxia-inducible factor-2α (HIF-2α) mediates the effects of hypoxia on the promotion of HeLa cell viability, colony formation, and invasion capacity in vitro
More from this journal
The newest in Journal of Genetic Syndromes & Gene Therapy.
Commentary · 1 Jul 2026
Mitochondrial Genome Correction Approaches in Rare Energy Deficiency Syndromes
Perspective · 1 Jul 2026
Lentiviral Gene Integration Systems in Hematologic Genetic Blood Disorders
Perspective · 1 Jul 2026
Programmable RNA Editing Systems in Congenital Skeletal Dysplasia Disorders
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Genetic Syndromes & Gene Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Thierry Leveillard”

